Early detection of acute kidney injury by newly established biomarkers

Early detection of acute kidney injury by newly established biomarkers - New biomarkers in acute kidney injury

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001843

Enrollment

100

Registered

2009-04-02

Start date

2009-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury (AKI)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Urine samples are obtained from patients who are admitted into St.marianna university hospital.Inclusion criteria is following: 1.Patients whose serum-creatinine level are less than 1.5 mg/dl at the start. The kidney transplant patient who is doubted of acute rejection and admitted to urology or the patient of admitted to cardiovascular surgery for elective operation. 2.Patients whose serum creatinine levels were equal to or more than 1.5 mg/dl, and whose conditions were included into modification RIFLE criteria. 3.The patient whose informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1.The patients with chronic renal failure 2.The patients with atrophic kidney

Design outcomes

Primary

Measure	Time frame
To evaluate whether levels of urinary L-FABP is a useful biomarker for early detection of AKI or monitoring the disease.	—

Secondary

Measure	Time frame
1) Measurement of urinary L-FABP and another biomarkers 2) Comparison urinary L-FABP level with severity of AKI 3) Determination of cut off values of the biomarkers in the detection of AKI	—

Countries

Japan

Contacts

Public ContactKatsuomi Matsui

St.Marianna University School of Medicine Department of nephrology and hypertension

m.katsuomi@marianna-u.ac.jp044-977-8111

Outcome results